Patton RL, Kalback WM, Esh CL, Kokjohn TA, Van Vickle GD, Luehrs DC, Kuo YM, Lopez J, Brune D, Ferrer I, Masliah E, Newel AJ, Beach TG, Castaño EM, Roher AE. Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am J Pathol. 2006 Sep;169(3):1048-63. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This is an important study of the consequences of Abeta immunization on Abeta peptides in patients treated with AN-1792.

    View all comments by John Trojanowski

  2. New data from immunization studies.

    View all comments by Hilkka Soininen

  3. Soluble Abeta levels are elevated in AN-1792 vaccinated patients.

    View all comments by Charles Glabe

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. AD Immunotherapy: Toward Prevention, DNA-based Vaccines?
  2. New Vaccine Divides T and B Cell Epitopes to Conquer Aβ